Showing 521-530 of 9652 results for "".
To Sell or Not to Sell to Private Equity?
https://practicaldermatology.com/conferences/scale-2023/to-sell-or-not-to-sell-to-private-equity/20195/Joel L. Cohen, MD, and George Hruza MD, discuss the pros and cons of selling to private equity. Pros include back-office support and better pricing on technology and supplies, while cons can include giving up autonomy.Social Media Success Strategies
https://practicaldermatology.com/topics/practice-management/social-media-success-strategies/20191/Doris Day, MD, shares some best practices on using social media to educate patients and dispel myths perpetuated by ‘skinfluencers’.Weighing the Safety of Sunscreens
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-safety-of-sunscreens/20172/Adam Friedman, MD, provides compelling reasons to question the recent studies on sunscreen safety.Redefining the Discourse: Psoriasis in Diverse Skin Tones
https://practicaldermatology.com/topics/psoriasis/redefining-the-discourse-psoriasis-in-diverse-skin-tones/23856/A lack of representation for underserved ethno-racial groups in clinical data and research is an underlying factor contributing to physicians’ challenges with effectively diagnosing and treating psoriasis in patients with diverse skin tones.Balance Sheet Management
https://practicaldermatology.com/topics/practice-management/balance-sheet-management/23847/Understanding the health of your business is essential for success.A Dermatologist’s Guide to LinkedIn Marketing
https://practicaldermatology.com/topics/practice-management/a-dermatologists-guide-to-linkedin-marketing/23830/Understanding unique features of the social network allows practices to optimize their brand engagement.Never Underestimate the Power of Visual Communication in Your Dermatology Marketing
https://practicaldermatology.com/topics/practice-management/never-underestimate-the-power-of-visual-communication-in-your-dermatology-marketing/23792/Colors, shapes, images, and more combine to send a message to potential and existing patients. What is your practice saying?DermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatologySaved by the Bell: Update on Proposed Medicare Payment Cuts
https://practicaldermatology.com/topics/practice-management/saved-by-the-bell-update-on-proposed-medicare-payment-cuts/23640/Most cuts have been suspended—at least for a while.Update on UV Safety
https://practicaldermatology.com/topics/skin-cancer-photoprotection/update-on-uv-safety/23632/The facts about recent developments in sunscreen and strategies for patient safety.